v3.26.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

The following table sets forth the computation of the basic and diluted net loss per share:

 

   March 31, 2026   March 31, 2025 
   Three months ended 
   March 31, 2026   March 31, 2025 
         
Numerator:          
Net loss  $(5,234,692)  $(3,809,700)
Denominator:          
Weighted average shares outstanding   9,914,832    5,297,899 
Net loss per share, basic and diluted  $(0.53)  $(0.72)
SCHEDULE OF ANTI-DILUTIVE EFFECT

The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have had an anti-dilutive effect:

 

   March 31, 2026   March 31, 2025 
Restricted Stock options   21,742    41,012 
Restricted Stock Units   117,857    277,095 
Performance Stock units   50,658    50,658 
Sponsor Earnout Shares (Note 4)*   -    - 
Public warrants   486,413    486,413 
Private warrants   556,666    556,666 
Inducement warrants   -    958,400 
Short term loan warrants   86,591    - 
Private placement warrants   6,425    - 
2025 Convertible note shares   822,340    - 
2025 Convertible note warrants   411,245    - 

 

* The Sponsor Earnout Shares (as defined in the Business Combination Agreement) were not included for purposes of calculating the number of diluted shares outstanding as of March 31, 2026, as the Sponsor Earnout Shares remain contingently forfeitable, as the conditions have not been met.